News

Hematologic Malignancies Testing Market Forecast, Revenue, Demand, Growth and Key Companies Valuation by 2028

September 15, 2021

The global Hematologic Malignancies Testing Market is forecasted to be worth USD 5.45 Billion by 2027, according to a current analysis by Emergen Research. The rapid growth of the global market for Hematologic Malignancies Testing can be attributed to the rising prevalence of Leukemia and Multiple myeloma. 10% of all hematologic cancers are due to multiple myeloma. It is estimated that about 12,830 deaths from multiple myeloma (7,190 in men and 5,640 in women) will happen in 2024. The report provides Hematologic Malignancies Testing market forecast, supported by detailed insights historical data and revenues, past and current market trends, industry trends, consumer trends, market size, market share, market growth, along with ranging impacts of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2024–2028. The report includes profiles of major players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/368

Global Hematologic Malignancies Testing market forecast has been provided following thorough study, focus, comparison, and analysis of a varying range of factors and past market forecast and present outcomes. Hematologic Malignancies Testing Market forecast is made possible through, but has not been limited to, a study and analysis of a variety of factors and trends, and these are verified through interviews with industry experts and companies operating in the market. Besides, increasing awareness among patients and healthcare professionals about the initial diagnosis of Hematologic Malignancies is anticipated to stimulate growth over the forecasted timeframe. Furthermore, the rising emphasis on personalized medicine is also expected to drive the market growth of global Hematologic Malignancies Testing. This procedure can be used in a very particular way to identify and diagnose disorders, classifying those through hereditary variance instead of by symptoms. This encourages more precise and efficient therapies, strengthening the prognosis of patients.

Browse Full Report Description with TOC@ https://www.emergenresearch.com/industry-report/hematologic-malignancies-testing-market

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Hematologic Malignancies Testing Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2024 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Rising focus by major companies on product/service expansion into new and untapped domestic markets, increasing investments in strategic agreements, favourable government policies and regulations, and growing competition in the market are some major trends observed in the Hematologic Malignancies Testing market. Development of more advanced offerings is driving rising demand and deployment in respective sectors/industries, and this is expected to drive Hematologic Malignancies Testing market revenue growth to a significant extent over the forecast period.

Region wise performance of the Hematologic Malignancies Testing industry

North America Hematologic Malignancies Testing market forecast is expected to remain significantly positive in terms of revenue share between 2024 and 2028. In addition, North America Hematologic Malignancies Testing market revenue share is expected to remain comparatively larger than that of other regional markets from 2024 to 2028.

Asia Pacific registered fastest revenue CAGR in 2024, and the Hematologic Malignancies Testing market forecast is that this trend is expected to continue going ahead. Market forecast states that revenue share contribution from China, India, and South Korea is expected to remain robust till 2028.

Europe Hematologic Malignancies Testing market forecast is positive currently, with revenue growth expected to remain steady between 2024 and 2028. Robust focus on research and development initiatives by major firms and changing trends and demographics in countries in the region are some factors expected to continue to support Hematologic Malignancies Testing market growth.

Key Highlights From The Report

In March 2024, Sysmex Corporation received japan marketing clearance for BGI Genomics Coronavirus kit distribution. This initiative will strengthen its position in Japan.
During the forecast timeline, the Next-generation sequencing segment will hold the largest market with a CAGR of 14.8%. In next-generation sequencing, the steadily developing cohort of technologies allowing the detection of gene variations present in Rna and DNA. In the case of hematologic malignancies, such differences provide diagnostic relevance.
It is expected that the Leukemia segment will hold the largest market throughout the forecasted period. The demand for early diagnosis and growing the cases of leukemia are expected to drive the growth of this segment.
The region of North America accounts for the largest market in the forecast timeline. The presence of the key players, and the existing advanced healthcare facilities, are the forces responsible for growth.
Key participants include ArcherDx, Inc., Bio-Rad Laboratories, Inc., Sysmex Corporation, Invitae Corporation, NeoGenomics Laboratories, Inc., Abbott Laboratories, Cancer Genetics Inc., Adaptive Biotechnologies Corporation, Asuragen, Inc., and Invivoscribe, Inc. among others.

Request customized copy of Hematologic Malignancies Testing report@ https://www.emergenresearch.com/request-for-customization/368

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Table of Content

Chapter 1. Methodology & Sources

1.1. Hematologic Malignancies Testing Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Hematologic Malignancies Testing Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2024-2028

Chapter 3. Key Insights

Chapter 4. Hematologic Malignancies Testing Market Segmentation & Impact Analysis

4.1. Hematologic Malignancies Testing Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Hematologic Malignancies Testing Market indicators analysis

4.2.2. Hematologic Malignancies Testing Market drivers analysis

4.2.2.1. Rapid urbanization and industrialization

4.2.2.2. Stringent government regulations regarding carbon emissions

4.2.2.3. Increasing prevalence of respiratory diseases

4.2.2.4. Rising need to enhance indoor air quality

4.2.3. Hematologic Malignancies Testing Market restraints analysis

4.2.3.1. High cost associated with the maintenance of Hematologic Malignancies Testing products

4.2.3.2. Availability of renewable sources of energy

4.3. Technological Insights

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive Metric Space Analysis

4.7. Price trend Analysis

4.8. Covid-19 Impact Analysis

Continued….

Avail Discount on Hematologic Malignancies Testing Market Report@ https://www.emergenresearch.com/request-discount/368

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Hematologic Malignancies Testing industry for the forecast period 2024-2027?
What are the major driving forces expected to impact the development of the Hematologic Malignancies Testing market across different regions?
Who are the major driving forces expected to decide the fate of the Hematologic Malignancies Testing industry worldwide?
Who are the prominent market players making a mark in the Hematologic Malignancies Testing market with their winning strategies?
Which Hematologic Malignancies Testing industry trends are likely to shape the future of the industry during the forecast period 2024-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the Hematologic Malignancies Testing market?

Why Choose Emergen Research?